Frec Markets’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.3M Buy
5,281
+3,663
+226% +$932K 0.08% 286
2026
Q2
$487K Buy
+1,618
New +$488K 0.04% 520

Other funds holding ALNY

Frec Markets's ALNY Position: Q3 2026 in Review

Frec Markets increased its Alnylam Pharmaceuticals (ALNY) stake by 226% in Q3 2026, buying an estimated $932K and bringing the position to 5,281 shares worth $1.3M. The position accounts for 0.08% of the portfolio, ranked #286.

Frec Markets first reported a position in ALNY in Q2 2026 and has held it in 2 quarters since. 730 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Frec Markets held 5,281 shares of Alnylam Pharmaceuticals worth $1.3M as of Q3 2026.
  • Frec Markets bought 3,663 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $932K.
  • Alnylam Pharmaceuticals made up 0.08% of Frec Markets's portfolio in Q3 2026, its #286 holding.
  • Frec Markets first reported a position in Alnylam Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • 730 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Frec Markets's 13F filing for Q3 2026, filed 16 Nov 2026.